HAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.

Not yet recruitingOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

High Altitude Pulmonary HypertensionSleep Apnea

All Listed Sponsors

collaborator

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

OTHER_GOV

lead

University of Zurich

OTHER

NCT06489730 - HAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders. | Biotech Hunter | Biotech Hunter